Cargando…

Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues

Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchyma...

Descripción completa

Detalles Bibliográficos
Autores principales: Moioli, Eduardo K., Clark, Paul A., Chen, Mo, Dennis, James E., Erickson, Helaman P., Gerson, Stanton L., Mao, Jeremy J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597748/
https://www.ncbi.nlm.nih.gov/pubmed/19081793
http://dx.doi.org/10.1371/journal.pone.0003922
_version_ 1782161897541337088
author Moioli, Eduardo K.
Clark, Paul A.
Chen, Mo
Dennis, James E.
Erickson, Helaman P.
Gerson, Stanton L.
Mao, Jeremy J.
author_facet Moioli, Eduardo K.
Clark, Paul A.
Chen, Mo
Dennis, James E.
Erickson, Helaman P.
Gerson, Stanton L.
Mao, Jeremy J.
author_sort Moioli, Eduardo K.
collection PubMed
description Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration. In this study, we tested this hypothesis by using bone as a model whose regeneration is impaired unless it is vascularized. Hematopoietic stem/progenitor cells (HSCs) and mesenchymal stem/progenitor cells (MSCs) were isolated from each of three healthy human bone marrow samples and reconstituted in a porous scaffold. MSCs were seeded in micropores of 3D calcium phosphate (CP) scaffolds, followed by infusion of gel-suspended CD34(+) hematopoietic cells. Co-transplantation of CD34(+) HSCs and CD34(−) MSCs in microporous CP scaffolds subcutaneously in the dorsum of immunocompromized mice yielded vascularized tissue. The average vascular number of co-transplanted CD34(+) and MSC scaffolds was substantially greater than MSC transplantation alone. Human osteocalcin was expressed in the micropores of CP scaffolds and was significantly increased upon co-transplantation of MSCs and CD34(+) cells. Human nuclear staining revealed the engraftment of transplanted human cells in vascular endothelium upon co-transplantation of MSCs and CD34(+) cells. Based on additional in vitro results of endothelial differentiation of CD34(+) cells by vascular endothelial growth factor (VEGF), we adsorbed VEGF with co-transplanted CD34(+) and MSCs in the microporous CP scaffolds in vivo, and discovered that vascular number and diameter further increased, likely owing to the promotion of endothelial differentiation of CD34(+) cells by VEGF. Together, co-transplantation of hematopoietic and mesenchymal stem/progenitor cells may improve the regeneration of vascular dependent tissues such as bone, adipose, muscle and dermal grafts, and may have implications in the regeneration of internal organs.
format Text
id pubmed-2597748
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-25977482008-12-15 Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues Moioli, Eduardo K. Clark, Paul A. Chen, Mo Dennis, James E. Erickson, Helaman P. Gerson, Stanton L. Mao, Jeremy J. PLoS One Research Article Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration. In this study, we tested this hypothesis by using bone as a model whose regeneration is impaired unless it is vascularized. Hematopoietic stem/progenitor cells (HSCs) and mesenchymal stem/progenitor cells (MSCs) were isolated from each of three healthy human bone marrow samples and reconstituted in a porous scaffold. MSCs were seeded in micropores of 3D calcium phosphate (CP) scaffolds, followed by infusion of gel-suspended CD34(+) hematopoietic cells. Co-transplantation of CD34(+) HSCs and CD34(−) MSCs in microporous CP scaffolds subcutaneously in the dorsum of immunocompromized mice yielded vascularized tissue. The average vascular number of co-transplanted CD34(+) and MSC scaffolds was substantially greater than MSC transplantation alone. Human osteocalcin was expressed in the micropores of CP scaffolds and was significantly increased upon co-transplantation of MSCs and CD34(+) cells. Human nuclear staining revealed the engraftment of transplanted human cells in vascular endothelium upon co-transplantation of MSCs and CD34(+) cells. Based on additional in vitro results of endothelial differentiation of CD34(+) cells by vascular endothelial growth factor (VEGF), we adsorbed VEGF with co-transplanted CD34(+) and MSCs in the microporous CP scaffolds in vivo, and discovered that vascular number and diameter further increased, likely owing to the promotion of endothelial differentiation of CD34(+) cells by VEGF. Together, co-transplantation of hematopoietic and mesenchymal stem/progenitor cells may improve the regeneration of vascular dependent tissues such as bone, adipose, muscle and dermal grafts, and may have implications in the regeneration of internal organs. Public Library of Science 2008-12-15 /pmc/articles/PMC2597748/ /pubmed/19081793 http://dx.doi.org/10.1371/journal.pone.0003922 Text en Moioli et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Moioli, Eduardo K.
Clark, Paul A.
Chen, Mo
Dennis, James E.
Erickson, Helaman P.
Gerson, Stanton L.
Mao, Jeremy J.
Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title_full Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title_fullStr Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title_full_unstemmed Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title_short Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
title_sort synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597748/
https://www.ncbi.nlm.nih.gov/pubmed/19081793
http://dx.doi.org/10.1371/journal.pone.0003922
work_keys_str_mv AT moiolieduardok synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT clarkpaula synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT chenmo synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT dennisjamese synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT ericksonhelamanp synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT gersonstantonl synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues
AT maojeremyj synergisticactionsofhematopoieticandmesenchymalstemprogenitorcellsinvascularizingbioengineeredtissues